BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 25478927)

  • 1. Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis.
    McCann GA; Cohn DE; Jewell EL; Havrilesky LJ
    Gynecol Oncol; 2015 Feb; 136(2):300-4. PubMed ID: 25478927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of sentinel lymph node biopsy in the treatment of early-stage vulvar cancer.
    Erickson BK; Divine LM; Leath CA; Straughn JM
    Int J Gynecol Cancer; 2014 Oct; 24(8):1480-5. PubMed ID: 25188883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
    Brar H; Hogen L; Covens A
    Cancer; 2017 May; 123(10):1751-1759. PubMed ID: 28117888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
    Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar cancer.
    Johann S; Klaeser B; Krause T; Mueller MD
    Gynecol Oncol; 2008 Sep; 110(3):324-8. PubMed ID: 18582920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis.
    Verry H; Lord SJ; Martin A; Gill G; Lee CK; Howard K; Wetzig N; Simes J
    Br J Cancer; 2012 Mar; 106(6):1045-52. PubMed ID: 22415293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany.
    Hampl M; Hantschmann P; Michels W; Hillemanns P;
    Gynecol Oncol; 2008 Nov; 111(2):282-8. PubMed ID: 18804850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on sentinel lymph node biopsy for early-stage vulvar cancer.
    Slomovitz BM; Coleman RL; Oonk MH; van der Zee A; Levenback C
    Gynecol Oncol; 2015 Aug; 138(2):472-7. PubMed ID: 26022527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial versus deep inguinal nodal dissection for vulvar cancer staging.
    Mattson J; Emerson J; Underwood A; Sun G; Mott SL; Kulkarni A; Robison K; Hill EK
    Gynecol Oncol; 2022 Sep; 166(3):465-470. PubMed ID: 35781163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of vulvar cancer.
    Fuh KC; Berek JS
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):45-62. PubMed ID: 22244661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?
    Farrell R; Gebski V; Hacker NF
    Int J Gynecol Cancer; 2014 May; 24(4):813-9. PubMed ID: 24662129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.
    Reade CJ; Jimenez W; O'Reilly D; Covens A
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1053-1065. PubMed ID: 23231843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?
    Clements AE; Tierney BJ; Cohn DE; Straughn JM
    Gynecol Oncol; 2013 Feb; 128(2):166-70. PubMed ID: 23078763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis.
    Suidan RS; Sun CC; Cantor SB; Mariani A; Soliman PT; Westin SN; Lu KH; Giordano SH; Meyer LA
    Obstet Gynecol; 2018 Jul; 132(1):52-58. PubMed ID: 29889752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node detection by lymphoscintigraphy and sentinel lymph node biopsy in vulvar melanoma.
    Trifirò G; Travaini LL; Sanvito F; Pacifici M; Mallia A; Ferrari ME; Vertua A; Maggioni A; Paganelli G; Sideri MG
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):736-41. PubMed ID: 20107788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declining use of inguinofemoral lymphadenectomy in the treatment of clinically negative, pathologic node positive vulvar cancer.
    Mokhtech M; Gao SJ; Kassick M; Menderes G; Damast S
    Gynecol Oncol; 2022 Jul; 166(1):61-68. PubMed ID: 35550710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.
    Robison K; Steinhoff MM; Granai CO; Brard L; Gajewski W; Moore RG
    Gynecol Oncol; 2006 Apr; 101(1):24-7. PubMed ID: 16246399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An initial experience of the use of sentinel lymph node biopsy in squamous cell cancer of the vulva].
    Li B; Wu LY; Liu L; Zhang R; Zhang GY; Yu GZ
    Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):364-8. PubMed ID: 19573313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors of vulvar cancer].
    Sago N; Nakao Y; Iwasaka T
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):1991-7. PubMed ID: 17197741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.